Health Canada Authorizes Nemluvio® for Eczema and Prurigo Nodularis
Health Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
Browsing Tag
Understand Canada’s healthcare system—wait times, access, and policies explained. Stay informed with expert analysis and updates.